HAP Trading’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Hold |
0
| – | – | – | 239 |
|
|
2022
Q4 | – | Sell |
-17,834
| Closed | -$225K | – | 328 |
|
|
2022
Q3 | $225K | Sell |
17,834
-4,023
| -18% | -$50.8K | 0.02% | 282 |
|
|
2022
Q2 | $231K | Sell |
21,857
-13,279
| -38% | -$140K | 0.01% | 343 |
|
|
2022
Q1 | $571K | Sell |
35,136
-60,640
| -63% | -$985K | 0.02% | 295 |
|
|
2021
Q4 | $1.33M | Buy |
95,776
+22,023
| +30% | +$305K | 0.04% | 245 |
|
|
2021
Q3 | $1.06M | Buy |
73,753
+56,546
| +329% | +$813K | 0.03% | 273 |
|
|
2021
Q2 | $272K | Buy |
+17,207
| New | +$272K | 0.01% | 480 |
|
|
2021
Q1 | – | Hold |
0
| – | – | – | 505 |
|
|
2020
Q4 | – | Hold |
0
| – | – | – | 498 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 358 |
|
|
2020
Q2 | – | Hold |
0
| – | – | – | 343 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 279 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 300 |
|
|
2019
Q3 | – | Hold |
0
| – | – | – | 283 |
|
|
2019
Q2 | – | Hold |
0
| – | – | – | 275 |
|
|
2017
Q1 | – | Sell |
-51,468
| Closed | -$326K | – | 285 |
|
|
2016
Q4 | $326K | Buy |
+51,468
| New | +$326K | 0.02% | 224 |
|